NCT07759622

Brief Summary

Cesarean section (CS) rates have rapidly increased worldwide, with projections suggesting that by 2030, one in every three births will be by CS (1). In Sweden, rates have more than doubled from 9% in the 1990s, to 20% in 2024 (2). While CS can be a life-saving procedure when medically indicated, non-essential CS increase the risk of complications and have been linked to increased maternal morbidity and even death, neonatal respiratory issues, and longer recovery times (3). They also place added strain on already burdened healthcare systems by increasing the use of medical resources and staff capacity. The purpose of this project is to evaluate the use of the "Cesarean Bundle", a three-part intervention designed to improve patient-clinician communication and trust. Primary Aim: To evaluate the impact of the "Cesarean Bundle" in improving patient-clinician communication and trust compared to standard care. Hypothesis: Use of the "Cesarean Bundle" will improve patients' trust in their healthcare providers. Secondary Aim: To evaluate whether adoption of the "Cesarean Bundle" is associated with changes in cesarean section rates, especially among low-risk obstetric populations. Hypothesis: Implementation of the "Cesarean Bundle" will be associated with a reduction in overall cesarean section rates, particularly among low-risk pregnancies.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
260

participants targeted

Target at P75+ for not_applicable

Timeline
115mo left

Started May 2026

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress3%
May 2026Dec 2035

Study Start

First participant enrolled

May 5, 2026

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

June 26, 2026

Completed
2 months until next milestone

First Posted

Study publicly available on registry

August 12, 2026

Completed
3.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 15, 2030

Expected
5.6 years until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2035

Last Updated

August 12, 2026

Status Verified

May 1, 2026

Enrollment Period

4 years

First QC Date

June 26, 2026

Last Update Submit

August 6, 2026

Conditions

Keywords

Cesarean SectionPlanned CesareanCesarean BundleDecision Support ToolShared Decision-MakingPatient-Clinician CommunicationPatient TrustMaternal OutcomesNeonatal OutcomesPregnancyObstetricsVaginal BirthRobson ClassificationImplementation ScienceHealth Care Quality Improvement

Outcome Measures

Primary Outcomes (1)

  • Patient-Reported Trust in the Care Team

    Patient-Reported Trust in the Care Team Measured using the Health Care Relationship Trust Scale-Revised (HCRTS-R), a validated questionnaire assessing patients' trust in their healthcare providers following consultation for planned cesarean section. Each of the survey's 13 items is scored individually on a five-point scale (0 to 4), where the item score reflects the patient's immediate assessment of specific relational experiences, such as active listening, truth-telling, and respect for privacy. After converting one reverse-worded question to ensure that higher numbers consistently reflect stronger alignment with positive relational attributes, the individual item scores are summed to generate a cumulative total score ranging from 0 to 52. Within this spectrum, the higher the score, the better the reported trust and communication.

    Pilot: 12-18 months; Actual study 48 months

Secondary Outcomes (4)

  • Cesarean section rates

    Pilot: 12-18 months. Actual study: 48-54 months as some cesarean section may be reported at later date after the pregnancy has led to the birth of the baby.

  • Maternal outcome

    Pilot: 12-18 months. Main study: 48-54 months as some maternal outcomes may be reported at later date after the pregnancy has led to the birth of the baby.

  • Neonatal outcome

    Pilot: 12-18 months. Actual study: 48-54 months depending on when data is available from the patient charts and once the pregnancy has led to birth of the baby

  • Patient-Reported Experience

    Pilot 12-18 months. Actual study 48-54 months

Study Arms (2)

Intervention: Cesarean Bundle

ACTIVE COMPARATOR

Cesarean Bundle (structured discussion guide, mandatory second/team opinion, and regular team reviews/audits)

Other: Cesarean Bundle

Control Arm

NO INTERVENTION

Standard care (usual clinical practice without structured tools)

Interventions

The Cesarean Bundle is a structured, three-component clinical intervention designed to support evidence-based and shared decision-making for planned cesarean sections: 1. Cesarean Discussion Guide: A standardized decision-support tool used during all consultations for planned cesarean section. It incorporates clinical data, risk stratification (e.g., Robson classification), and clear information on short- and long-term risks and benefits of cesarean versus vaginal birth, while also capturing patient preferences and values. 2. Mandatory Second/team Opinion: All requests for planned cesarean section require review and approval by a second clinician/team before a final decision is made. 3. Regularl Multidisciplinary Team Meetings: Regular team-based reviews of cases and decision-making patterns to promote consistency, reflection, and adherence to evidence-based practice. The intervention is integrated into routine care, with minimal disruption to standard workflows, and is support

Intervention: Cesarean Bundle

Eligibility Criteria

Age18 Years+
Sexfemale(Gender-based eligibility)
Gender Eligibility DetailsBiological sex due to pregnancy related condition
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Pregnant women aged ≥18 years
  • Referred for consultation regarding planned cesarean section
  • Able to provide informed consent (with interpreter support if needed)

You may not qualify if:

  • Women with an absolute medical indication for cesarean section (e.g., placenta previa), where shared decision-making is not applicable
  • Women who decline participation in the study components (e.g., surveys/interviews)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Skånes university hospital

Malmö, Sweden

RECRUITING

Related Publications (15)

  • 15) RE-AIM. Reach Effectiveness Adoption Implementation Maintenance [Internet]. Available from: https://re-aim.org

    BACKGROUND
  • Bova C, Fennie KP, Watrous E, Dieckhaus K, Williams AB. The health care relationship (HCR) trust scale: development and psychometric evaluation. Res Nurs Health. 2006 Oct;29(5):477-88. doi: 10.1002/nur.20158.

    PMID: 16977644BACKGROUND
  • Zaigham M, Varallo J, Thangaratinam S, Nicholson W, H A Visser G. Global disparities in caesarean section rates: Why indication-based metrics are needed. PLOS Glob Public Health. 2024 Feb 6;4(2):e0002877. doi: 10.1371/journal.pgph.0002877. eCollection 2024. No abstract available.

    PMID: 38319901BACKGROUND
  • 12) Robson MS. Classification of caesarean sections. Fetal and Maternal Medicine Review 2001;12(1):23-39.

    BACKGROUND
  • El Radaf V, Campos LN, Savona-Ventura C, Mahmood T, Zaigham M. Robson ten group classification system for Caesarean sections across Europe: A systematic review and meta-analysis. Eur J Obstet Gynecol Reprod Biol. 2025 Feb;305:178-198. doi: 10.1016/j.ejogrb.2024.11.052. Epub 2024 Dec 4.

    PMID: 39705988BACKGROUND
  • Bermudez-Tamayo C, Fernandez Ruiz E, Pastor Moreno G, Maroto-Navarro G, Garcia-Mochon L, Perez-Ramos FJ, Cano-Aguilar A, Velez MDP. Barriers and enablers in the implementation of a program to reduce cesarean deliveries. Reprod Health. 2017 Aug 29;14(1):106. doi: 10.1186/s12978-017-0369-3.

    PMID: 28851394BACKGROUND
  • Chaillet N, Dube E, Dugas M, Francoeur D, Dube J, Gagnon S, Poitras L, Dumont A. Identifying barriers and facilitators towards implementing guidelines to reduce caesarean section rates in Quebec. Bull World Health Organ. 2007 Oct;85(10):791-7. doi: 10.2471/blt.06.039289.

    PMID: 18038061BACKGROUND
  • Kingdon C, Downe S, Betran AP. Interventions targeted at health professionals to reduce unnecessary caesarean sections: a qualitative evidence synthesis. BMJ Open. 2018 Dec 16;8(12):e025073. doi: 10.1136/bmjopen-2018-025073.

    PMID: 30559163BACKGROUND
  • Kingdon C, Downe S, Betran AP. Women's and communities' views of targeted educational interventions to reduce unnecessary caesarean section: a qualitative evidence synthesis. Reprod Health. 2018 Jul 24;15(1):130. doi: 10.1186/s12978-018-0570-z.

    PMID: 30041661BACKGROUND
  • Opiyo N, Kingdon C, Oladapo OT, Souza JP, Vogel JP, Bonet M, Bucagu M, Portela A, McConville F, Downe S, Gulmezoglu AM, Betran AP. Non-clinical interventions to reduce unnecessary caesarean sections: WHO recommendations. Bull World Health Organ. 2020 Jan 1;98(1):66-68. doi: 10.2471/BLT.19.236729. Epub 2019 Nov 29. No abstract available.

    PMID: 31902964BACKGROUND
  • WHO Recommendations Non-Clinical Interventions to Reduce Unnecessary Caesarean Sections. Geneva: World Health Organization; 2018. Available from http://www.ncbi.nlm.nih.gov/books/NBK532672/

    PMID: 30398818BACKGROUND
  • Caesarean section on maternal request: A systematic review and assessment of medical, health economic, ethical and social aspects [Internet]. Stockholm: Swedish Agency for Health Technology Assessment and Assessment of Social Services (SBU); 2021 Dec 22. Available from http://www.ncbi.nlm.nih.gov/books/NBK580955/

    PMID: 35675476BACKGROUND
  • Velebil P, Savona-Ventura C, Zaigham M, Mahmood T, Wladimiroff J, Louwen F. How to influence rising caesarean section rates in Europe? An invited scientific review by European Board and College of Obstetrics and Gynaecology (EBCOG). Eur J Obstet Gynecol Reprod Biol. 2025 Jul;311:113979. doi: 10.1016/j.ejogrb.2025.113979. Epub 2025 Apr 16.

    PMID: 40328050BACKGROUND
  • 2) Socialstyrelsen (National Board of Health and Welfare). Graviditeter, förlossningar och nyfödda barn: statistik 2023 [Internet].

    BACKGROUND
  • Betran AP, Ye J, Moller AB, Souza JP, Zhang J. Trends and projections of caesarean section rates: global and regional estimates. BMJ Glob Health. 2021 Jun;6(6):e005671. doi: 10.1136/bmjgh-2021-005671.

    PMID: 34130991BACKGROUND

Central Study Contacts

Mehreen Zaigham, PhD, MBBS

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
SINGLE GROUP
Model Details: Interventional Study Model: Stepped-Wedge Cluster Randomized Trial (Multicenter) with Pilot Pre-Post Phase The study includes an initial pilot phase followed by a national multicenter stepped-wedge cluster design. In the pilot phase, a pre-post design is used at selected sites (Malmö and Lund), where outcomes during a baseline (pre-intervention) period are compared with outcomes after implementation of the Cesarean Bundle. This phase evaluates feasibility, acceptability, and preliminary effects of the intervention. In the main study, participating hospitals (clusters) sequentially transition from standard care to the intervention at different time points according to a predefined schedule (stepped-wedge design). All sites begin in the control phase and cross over to the intervention phase over time, allowing each site to serve as its own control while accounting for temporal trends and ensuring all sites
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 26, 2026

First Posted

August 12, 2026

Study Start

May 5, 2026

Primary Completion (Estimated)

May 15, 2030

Study Completion (Estimated)

December 31, 2035

Last Updated

August 12, 2026

Record last verified: 2026-05

Data Sharing

IPD Sharing
Will share

De-identified individual participant data (IPD) will be shared, including demographic variables (e.g., age, parity, BMI), clinical characteristics (e.g., pregnancy and delivery data, indication for cesarean section), intervention exposure, and outcome measures (e.g., planned cesarean rates, maternal and neonatal outcomes, and patient-reported trust scores). Survey responses (e.g., HCRTS-R and acceptability/feasibility questionnaires) and relevant implementation metrics may also be included. All data will be pseudonymized, with direct identifiers removed, in accordance with GDPR and applicable data protection regulations.

Shared Documents
STUDY PROTOCOL, SAP

Locations